Testing of Covaxin to cure Covid-19 patients is all set to commence in Tamil Nadu from today (Wednesday, 23d July).
As per the plan, the vaccine will be administered to 10 healthy volunteers at a private hospital in Kattankulathur.
These volunteers will be kept under observation for 14 days.
Recently, approval was given by the Drug Controller General of India for human clinical trials for the vaccine called Covaxin.
According to the Indian Council for Medical Research (ICMR), the vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune.
ICMR and Bharat Biotech International Limited, Hyderabad, are jointly working for the preclinical as well as clinical development of this vaccine.
Besides Bharat Biotech, at least five other Indian companies are working on a vaccine for the deadly coronavirus while similar efforts are underway in different countries.